Figure 3From: MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4MTT assay revealed that the anti-tumour effects cisplatin in the miR-182 downregulated cells were significantly profound than in control cells (*P <0.05). Data are meanāĀ±āSD of three experiments.Back to article page